Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion type Assertion NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_head.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion description "[Our results demonstrate tumor-specific accumulation and therapeutic efficacy of radioiodine after MSC-mediated NIS gene delivery in HCC tumors, opening the prospect of NIS-mediated radionuclide therapy of metastatic cancer using MSCs as gene delivery vehicles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_provenance.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion evidence source_evidence_literature NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_provenance.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion SIO_000772 21587211 NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_provenance.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion wasDerivedFrom befree-20140225 NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_provenance.
- NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_assertion wasGeneratedBy ECO_0000203 NP322597.RAAbVR152nNY_1eCKp3pdipJcBfLRMDoMJzIzm5DnTazM130_provenance.